All

Our Responsible Investment Annual Report is available online
10 October 2018

Our Responsible Investment Annual Report is available online

Click to upload our Responsible Investment Report

Read more
Vedanta Biosciences Announces Successful Phase 1a/1b Data Demonstrating Safety, Tolerability, and Proof of Mechanism for Lead, Rationally Defined Bacterial Consortium Product Candidate, VE303
4 October 2018

Vedanta Biosciences Announces Successful Phase 1a/1b Data Demonstrating Safety, Tolerability, and Proof of Mechanism for Lead, Rationally Defined Bacterial Consortium Product Candidate, VE303

Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally defined consortia of human...

Read the press release
Safer liver resection: Perioperative assessment of liver function with the LiMAx® test shortens hospital stay and reduces complications after liver surgery
25 July 2018

Safer liver resection: Perioperative assessment of liver function with the LiMAx® test shortens hospital stay and reduces complications after liver surgery

Clinical phase III trial at 6 specialized liver centers demonstrates impressive benefits of the LiMAx® test.

Read the press release
INTENTO DESIGN cooperates with STMICROELECTRONICS to accelerate analog design and migration of FD-SOI chips at functional level
12 June 2018

INTENTO DESIGN cooperates with STMICROELECTRONICS to accelerate analog design and migration of FD-SOI chips at functional level

Intento Design has announced its collaboration with STMicroelectronics (ST) in pushing forward its ID-XploreTM EDA software aimed to solve the critical design challenges in the...

Read the press release

By continuing your browsing on this site, you accept the use of cookies to carry out statistics of anonymous visits. Read more

Authorize Refuse